Advertisement
Screener

AGENUS INC (AGEN) Finance Lease, Liability, to be Paid, Year Two

2.8 / 5 stars · 68/120 Roast Me

AGENUS INC Finance Lease, Liability, to be Paid, Year Two

AGENUS INC (AGEN) had Finance Lease, Liability, to be Paid, Year Two of $17.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-16.

Financial Statements › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity

us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo · last filed 2026-03-16

  • 2025-12-31: Finance Lease, Liability, to be Paid, Year Two $17.00K.
  • 2024-12-31: Finance Lease, Liability, to be Paid, Year Two $107.00K.
  • 2023-12-31: Finance Lease, Liability, to be Paid, Year Two $4.83M.
  • 2022-12-31: Finance Lease, Liability, to be Paid, Year Two $9.81M.
Period endFinance Lease, Liability, to be Paid, Year Two
2025-12-31$17.00K
10-K · filed 2026-03-16
2024-12-31$107.00K
10-K · filed 2025-03-17
2023-12-31$4.83M
10-K · filed 2024-03-14
2022-12-31$9.81M
10-K · filed 2023-03-16
2021-12-31$248.00K
10-K · filed 2022-03-01
2020-12-31$67.00K
10-K · filed 2021-03-16
2020-09-30$67.00K
10-Q · filed 2020-11-09
2020-06-30$804.00K
10-Q · filed 2020-08-10
2020-03-31$804.00K
10-Q · filed 2020-05-11
2019-09-30$159.00K
10-Q · filed 2019-11-07
2019-06-30$159.00K
10-Q · filed 2019-08-09
2019-03-31$159.00K
10-Q · filed 2019-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60